Literature DB >> 9617567

Detection, cDNA cloning and sequencing of canine interleukin 12.

M Büttner1, G Belke-Louis, H J Rziha, C McInnes, O R Kaaden.   

Abstract

In canine peripheral blood mononuclear cells (PBMC) the mRNAs coding for both subunits of canine interleukin 12 (IL-12) were identified using reverse transcription polymerase chain reaction (RT-PCR). Stimulation of canine PBMC with Staphylococcus aureus strain Cowan plus Concanavalin A for 5 h resulted in significant mRNA synthesis. Likewise, inactivated vaccinia virus induced IL-12 mRNA synthesis, however with different kinetics. The complete nucleotide sequence for both IL-12 subunits was determined using rapid amplification of cDNA ends (RACE)-PCR and cloning of amplified specific cDNAs. Computer-aided amino acid (aa) sequence comparison of both canine IL-12 subunits revealed more than 80% identity with the amino acid sequences of six other mammalian species. Closest relationship was found to human, porcine, bovine and cervine IL-12. However, no reactivity was found with antibodies directed against human IL-12, when supernatants of stimulated canine PBMC were tested. Supernatants of canine PBMC stimulated for IL-12 release also induced interferon gamma (IFN-gamma) mRNA as detectable by RT-PCR; however, it was not clear whether IFN-gamma mRNA synthesis was due to an IL-12 specific effect or other stimuli. As to the stimulating effect of IL-12 on canine IFN-gamma mRNA synthesis, recombinant human IL-12 was found to be a good inducer. Since IL-12 is regarded a major regulatory molecule of T-cell-mediated immune response and cell growth our work on the cloning and sequencing of this cytokine from dogs lays the basis for future investigations on the biological and possible therapeutic role of canine IL-12.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617567     DOI: 10.1006/cyto.1997.0284

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.

Authors:  Ursa Lampreht; Urska Kamensek; Monika Stimac; Gregor Sersa; Natasa Tozon; Masa Bosnjak; Andreja Brozic; Geraldo Gileno de Sá Oliveira; Takayuki Nakagawa; Kohei Saeki; Maja Cemazar
Journal:  J Membr Biol       Date:  2015-04-04       Impact factor: 1.843

2.  Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.

Authors:  S D Reed; A Fulmer; J Buckholz; B Zhang; J Cutrera; K Shiomitsu; S Li
Journal:  Cancer Gene Ther       Date:  2010-02-12       Impact factor: 5.987

3.  Electrogene therapy with interleukin-12 in canine mast cell tumors.

Authors:  Darja Pavlin; Maja Cemazar; Andrej Cör; Gregor Sersa; Azra Pogacnik; Natasa Tozon
Journal:  Radiol Oncol       Date:  2010-09-22       Impact factor: 2.991

4.  Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy.

Authors:  Jeffry Cutrera; Glenn King; Pamela Jones; Kristin Kicenuik; Elias Gumpel; Xueqing Xia; Shulin Li
Journal:  J Cell Mol Med       Date:  2015-01-27       Impact factor: 5.310

Review 5.  IL-12 based gene therapy in veterinary medicine.

Authors:  Darja Pavlin; Maja Cemazar; Gregor Sersa; Natasa Tozon
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.